Pages that link to "Q45992064"
Jump to navigation
Jump to search
The following pages link to Hereditary angioedema caused by missense mutations in the factor XII gene: clinical features, trigger factors, and therapy. (Q45992064):
Displaying 50 items.
- Diagnosis and treatment of hereditary angioedema with normal C1 inhibitor (Q21245394) (← links)
- Examination of genetic variants involved in generation and biodisposition of kinins in patients with angioedema (Q23915359) (← links)
- Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group (Q27009012) (← links)
- Canadian hereditary angioedema guideline (Q30596332) (← links)
- Radiologic manifestations of angioedema (Q33671543) (← links)
- Obstetrical Complications and Outcome in Two Families with Hereditary Angioedema due to Mutation in the F12 Gene. (Q33854064) (← links)
- Recurrent angioedema and the threat of asphyxiation (Q33946601) (← links)
- Hereditary angioedema in women (Q34053769) (← links)
- Factor XII mutations, estrogen-dependent inherited angioedema, and related conditions (Q34060658) (← links)
- Management of upper airway edema caused by hereditary angioedema (Q34060670) (← links)
- 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema (Q34064761) (← links)
- Management of hereditary angioedema in pregnant women: a review. (Q34181274) (← links)
- Enzymatic assays for the diagnosis of bradykinin-dependent angioedema (Q34934680) (← links)
- Ecallantide is a novel treatment for attacks of hereditary angioedema due to C1 inhibitor deficiency (Q35096965) (← links)
- Defective glycosylation of coagulation factor XII underlies hereditary angioedema type III (Q35700453) (← links)
- Acquired form of angioedema of the head and neck related to a deficiency in c1-inhibitor: a case report with a review of the literature (Q36470474) (← links)
- WAO Guideline for the Management of Hereditary Angioedema (Q36834816) (← links)
- In pursuit of excellence: an integrated care pathway for C1 inhibitor deficiency. (Q36960231) (← links)
- Deficiency of plasminogen activator inhibitor 2 in plasma of patients with hereditary angioedema with normal C1 inhibitor levels (Q37119024) (← links)
- Hereditary angioedema type III (estrogen-dependent) report of three cases and literature review (Q37141749) (← links)
- Managing the female patient with hereditary angioedema (Q37741790) (← links)
- Enzymatic pathways in the pathogenesis of hereditary angioedema: The role of C1 inhibitor therapy (Q37796385) (← links)
- New Therapeutics in C1INH Deficiency: A Review of Recent Studies and Advances (Q37878994) (← links)
- Current management options for hereditary angioedema (Q38021414) (← links)
- Current pharmacotherapy of bradykinin-mediated angioedema. (Q38088259) (← links)
- Therapeutic management of hereditary angioedema due to C1 inhibitor deficiency. (Q38103288) (← links)
- Angioedema with normal laboratory values: the next step (Q38131740) (← links)
- Hereditary and acquired C1-inhibitor-dependent angioedema: from pathophysiology to treatment (Q38790498) (← links)
- How we manage persons with hereditary angioedema. (Q38806437) (← links)
- "Nuts and Bolts" of Laboratory Evaluation of Angioedema (Q38824626) (← links)
- Hereditary angioedema with normal C1 inhibitor and factor XII mutation: a series of 57 patients from the French National Center of Reference for Angioedema (Q38857834) (← links)
- Hormonal contraception and the development of autoimmunity: A review of the literature (Q40039972) (← links)
- Fatal laryngeal angioedema: a case report and a workup of angioedema in a forensic setting (Q41072058) (← links)
- Pediatric hereditary angioedema: an update. (Q41150906) (← links)
- Hereditary angioedema with normal C1-INH with versus without specific F12 gene mutations (Q41755059) (← links)
- Bradykinin receptor 2 antagonist (icatibant) for hereditary angioedema type III attacks. (Q43238249) (← links)
- Characterization of a partial exon 9/intron 9 deletion in the coagulation factor XII gene (F12) detected in two Turkish families with hereditary angioedema and normal C1 inhibitor (Q45867572) (← links)
- Thrombotic events associated with C1 esterase inhibitor products in patients with hereditary angioedema: investigation from the United States Food and Drug Administration adverse event reporting system database (Q46767796) (← links)
- Acute paediatric compartment syndrome of the hand caused by hereditary angiooedema (Q47575322) (← links)
- Clinical Utility Gene Card for hereditary angioedema with normal C1 inhibitor (HAEnC1). (Q48113779) (← links)
- Treatment for hereditary angioedema with normal C1-INH and specific mutations in the F12 gene (HAE-FXII). (Q51293534) (← links)
- One hypovolaemic shock…two kinin pathway abnormalities. (Q53232102) (← links)
- Benefits of progestin contraception in non-allergic angioedema (Q56977887) (← links)
- A single nucleotide deletion at the C1 inhibitor gene as the cause of hereditary angioedema: insights from a Brazilian family (Q58851164) (← links)
- Angioedema due to acquired C1-inhibitor deficiency: spectrum and treatment with C1-inhibitor concentrate (Q64099376) (← links)
- A novel mutation in the coagulation factor 12 gene in subjects with hereditary angioedema and normal C1-inhibitor (Q84782559) (← links)
- Hereditary angioedema with F12 mutation: first report of three cases associated with immune disorders (Q89105914) (← links)
- Treatment of patients with hereditary angioedema with the c.988A>G (p.Lys330Glu) variant in the plasminogen gene (Q89746358) (← links)
- Wolf in the sheep's clothing: intestinal angioedema mimicking infectious colitis (Q90641301) (← links)
- The International/Canadian Hereditary Angioedema Guideline (Q91584229) (← links)